{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:30:19Z","timestamp":1789252219541,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100023181","name":"Medical Research Agency","doi-asserted-by":"crossref","award":["KPOD.07.07-IW.07-0197\/24"],"award-info":[{"award-number":["KPOD.07.07-IW.07-0197\/24"]}],"id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11060-026-05600-9","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:13:31Z","timestamp":1778746411000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic accuracy of 1H-MRS in detecting the oncometabolite 2-hydroxyglutarate (2HG) in adult-type diffuse gliomas"],"prefix":"10.1007","volume":"177","author":[{"given":"Anna","family":"Hebda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Wawrzyniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Heinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Mazgaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sadowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Oczko-Wojciechowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Nowicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Chmielik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bobek-Billewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"5600_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"5600_CR2","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.97380","author":"Thien Nhat Tran N","year":"2022","unstructured":"Thien Nhat Tran N (2022) The distribution and significance of IDH mutations in gliomas. Cent Nerv Syst Tumors. https:\/\/doi.org\/10.5772\/intechopen.97380","journal-title":"Cent Nerv Syst Tumors"},{"key":"5600_CR3","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/neuonc\/noy113","volume":"20","author":"CH Suh","year":"2018","unstructured":"Suh CH, Kim HS, Jung SC, Choi CG, Kim SJ (2018) 2-Hydroxyglutarate MR spectroscopy for prediction of isocitrate dehydrogenase mutant glioma: a systemic review and meta-analysis using individual patient data. Neuro Oncol 20:1573\u20131583. https:\/\/doi.org\/10.1093\/neuonc\/noy113","journal-title":"Neuro Oncol"},{"key":"5600_CR4","doi-asserted-by":"publisher","first-page":"111062","DOI":"10.1016\/J.JOCN.2025.111062","volume":"133","author":"FA McHugh","year":"2025","unstructured":"McHugh FA, Jiang J, Luton H, Parkinson J, Cook R, Newey A et al (2025) 2-Hydroxyglutarate magnetic resonance spectroscopy for preoperative IDH molecular profiling \u2013 A review of the literature and real-world clinical translation in a busy neurosurgical neuro-oncology unit. J Clin Neurosci 133:111062. https:\/\/doi.org\/10.1016\/J.JOCN.2025.111062","journal-title":"J Clin Neurosci"},{"key":"5600_CR5","doi-asserted-by":"publisher","unstructured":"Choi C, Ganji SK, DeBerardinis RJ, Hatanpaa KJ, Rakheja D, Kovacs Z et al (2012) 2-Hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat Med 18. https:\/\/doi.org\/10.1038\/nm.2682","DOI":"10.1038\/nm.2682"},{"key":"5600_CR6","doi-asserted-by":"publisher","unstructured":"Andronesi OC, Kim GS, Gerstner E, Batchelor T, Tzika AA, Fantin VR et al (2012) Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. Sci Transl Med 4. https:\/\/doi.org\/10.1126\/scitranslmed.3002693","DOI":"10.1126\/scitranslmed.3002693"},{"key":"5600_CR7","doi-asserted-by":"publisher","unstructured":"Choi C, Raisanen JM, Ganji SK, Zhang S, McNeil SS, An Z et al Prospective longitudinal analysis of 2-hydroxyglutarate magnetic resonance spectroscopy identifies broad clinical utility for the management of patients with IDH-mutant glioma. J Clin Oncol 2016;34. https:\/\/doi.org\/10.1200\/JCO.2016.67.1222","DOI":"10.1200\/JCO.2016.67.1222"},{"key":"5600_CR8","doi-asserted-by":"publisher","unstructured":"Park SI, Suh CH, Guenette JP, Huang RY, Kim HS (2021) The T2-FLAIR mismatch sign as a predictor of IDH-mutant, 1p\/19q-noncodeleted lower-grade gliomas: a systematic review and diagnostic meta-analysis. Eur Radiol 31. https:\/\/doi.org\/10.1007\/s00330-020-07467-4","DOI":"10.1007\/s00330-020-07467-4"},{"key":"5600_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/nbm.70153","volume":"6","author":"V Tiwari","year":"2025","unstructured":"Tiwari V, Ganji SK, An Z, Pinho MC, Larry, Davis T et al (2025) NMR in biomedicine magnetic resonance spectroscopy of 2-hydroxyglutarate and glycine in adult subjects with brainstem gliomas. Elizabeth Maher 6:18. https:\/\/doi.org\/10.1002\/nbm.70153","journal-title":"| Elizabeth Maher"},{"key":"5600_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11060-022-04042-3","volume":"159","author":"AW Autry","year":"2022","unstructured":"Autry AW, Lafontaine M, Jalbert L, Phillips E, Phillips JJ, Villanueva-Meyer J et al (2022) Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas. J Neurooncol 159:43\u201352. https:\/\/doi.org\/10.1007\/s11060-022-04042-3","journal-title":"J Neurooncol"},{"key":"5600_CR11","doi-asserted-by":"publisher","unstructured":"Branzoli F, Di Stefano AL, Capelle L, Ottolenghi C, Valabr\u00e8gue R, Deelchand DK et al (2018) Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy. Neuro Oncol 20. https:\/\/doi.org\/10.1093\/neuonc\/nox214","DOI":"10.1093\/neuonc\/nox214"},{"key":"5600_CR12","doi-asserted-by":"publisher","unstructured":"Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30. https:\/\/doi.org\/10.1002\/mrm.1910300604","DOI":"10.1002\/mrm.1910300604"},{"key":"5600_CR13","doi-asserted-by":"publisher","unstructured":"Lin A, Andronesi O, Bogner W, Choi IY, Coello E, Cudalbu C et al (2021) Minimum Reporting Standards for in vivo Magnetic Resonance Spectroscopy (MRSinMRS): Experts\u2019 consensus recommendations. NMR Biomed 34. https:\/\/doi.org\/10.1002\/nbm.4484","DOI":"10.1002\/nbm.4484"},{"key":"5600_CR14","doi-asserted-by":"publisher","unstructured":"Wilson M, Andronesi O, Barker PB, Bartha R, Bizzi A, Bolan PJ et al (2019) Methodological consensus on clinical proton MRS of the brain: Review and recommendations. Magn Reson Med 82. https:\/\/doi.org\/10.1002\/mrm.27742","DOI":"10.1002\/mrm.27742"},{"key":"5600_CR15","doi-asserted-by":"publisher","unstructured":"Van Dijken BRJ, Jeltema HR, K\u0142os J, Van Laar PJ, Enting RH, Maatman RGHJ et al (2023) The correlation of in vivo MR spectroscopy and ex vivo 2-hydroxyglutarate concentration for the prediction of isocitrate dehydrogenase mutation status in diffuse glioma. Diagnostics 13:2791. https:\/\/doi.org\/10.3390\/diagnostics13172791","DOI":"10.3390\/diagnostics13172791"},{"key":"5600_CR16","doi-asserted-by":"publisher","unstructured":"Simpson R, Devenyi GA, Jezzard P, Hennessy TJ, Near J (2017) Advanced processing and simulation of MRS data using the FID appliance (FID-A)\u2014An open source, MATLAB-based toolkit. Magn Reson Med 77. https:\/\/doi.org\/10.1002\/mrm.26091","DOI":"10.1002\/mrm.26091"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05600-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05600-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05600-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:16:01Z","timestamp":1781262961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05600-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5600"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05600-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9266342\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article has been revised: In Reference no. 15, an incorrect first author name has been removed.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the institutional Ethics Committee (Approval Number: 97\/2025; Date: 18.09.2025). The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}